Rediscovering catatonia: The biography of a treatable syndrome

Acta Psychiatrica Scandinavica

Volumn 127, Issue S441, 2013, Pages 1-47

  Fink, Max ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Catatonia; Classification; Diagnosis; Schizophrenia; Tonic immobility; Treatment

Indexed keywords

AMOBARBITAL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; CYCLOPHOSPHAMIDE; DANTROLENE; DIAZEPAM; DIPHENHYDRAMINE; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; IMIPRAMINE; INSULIN; LITHIUM; LORAZEPAM; MESORIDAZINE; OLANZAPINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; TRIFLUOPERAZINE; ZOLPIDEM;

AKINETIC MUTISM; ANTI NMDAR ENCEPHALITIS; ANXIETY DISORDER; ARTICLE; AUTISM; AUTOMUTILATION; BEHAVIOR DISORDER; CATATONIA; CLINICAL EXAMINATION; CLINICAL FEATURE; CONDITIONING; CONVULSIVE THERAPY; DELIRIOUS MANIA; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; DRUG MARKETING; DRUG MEGADOSE; DSM-IV; ELECTIVE MUTISM; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; ENCEPHALITIS; EPIDEMIC ENCEPHALITIS; FEAR CONDITIONING; FEVER; GILLES DE LA TOURETTE SYNDROME; HEBEPHRENIA; HOSPITAL ADMISSION; HUMAN; IMMOBILIZATION; INTERNATIONAL CLASSIFICATION OF DISEASES; LABORATORY TEST; MALIGNANT HYPERTHERMIA; MELANCHOLIA; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL HOSPITAL; MOTOR DYSFUNCTION; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; NEUROTOXICITY; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PERVASIVE REFUSAL SYNDROME; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; PSYCHODYNAMICS; PSYCHOMOTOR DISORDER; PSYCHOSIS; PSYCHOTHERAPY; RIGIDITY; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SCIENTIFIC LITERATURE; SLEEP DISORDER; STUPOR; THYROID DISEASE; TONIC CLONIC SEIZURE; TONIC IMMOBILITY; TOXIC SEROTONIN SYNDROME; TREATMENT DURATION; TREATMENT INDICATION; TREMOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; HISTORY;

BENZODIAZEPINES; CATATONIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROCONVULSIVE THERAPY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA;

EID: 84878260778     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12038     Document Type: Article

References (266)

1. Wallace A. Creatures of accident. New York: Hill and Wang, 2006.
2. Arnold OH, Stepan H. Untersuchungen zur frage der akuten tödlichen katatonie. Wien Zeits Nervenheilk Grenzgeb 1952;4:235-258.
3. Greenberg LB, Gujavarty K. The neuroleptic malignant syndrome: review and report of three cases. Compr Psychiatry 1985;26:63-70.
4. Fink M. Is catatonia a primary indication for ECT? Convuls Ther 1990;6:1-4.
5. Fink M. Recognizing NMS as a type of catatonia. Neuropsychiatry Neuropsychol Behav Neurol 1995;8:75-76.
6. Fink M. Neuroleptic malignant syndrome: identification and treatment. Essential Psychopharmacol 1997;2:209-216.
7. Abrams R, Taylor MA. Catatonia, a prospective clinical study. Arch Gen Psychiatry 1976;33:579-581.
8. Abrams R, Taylor MA. Catatonia: prediction of response to somatic treatments. Am J Psychiatry 1977;134:78-80.
9. Fink M, Taylor MA. Catatonia: a separate category for DSM-IV? Integrative Psychiatry 1991;7:2-10.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th Edition. Washington DC: American Psychiatric Association, 1994.
11. Fink M, Taylor MA. Catatonia. A clinician's guide to diagnosis and treatment. Cambridge UK: Cambridge University Press, 2003.
12. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003;160:1233-1241.
13. Kahlbaum KL. Catatonia. Levi Y, Pridon T (trans). Baltimore: Johns Hopkins University Press, 1973.
14. Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol 2010;43:307-315.
15. Moskowitz A. "Scared Stiff": catatonia as an evolutionary-based fear response. Psycholog Rev 2004;111:984-1002.
16. Rosenberg, CE Disease and social order in America: perceptions and expectations. Milbank Q 1986;64(Suppl. 1):34-55.
17. Kahlbaum KL. Die Katatonie oder das Spannungsirresein: eine klinische form psychischer Krankheit. Berlin: Verlag August Hirshwald, 1874.
18. Rogers D. Motor disorder in psychiatry. Chichester UK: John Wiley & Sons, 1992.
19. Wachtel LE, Dhossche D. Self-injury in autism as an alternate sign of catatonia: implications for electroconvulsive therapy. Med Hypothes 2010;75:111-114.
20. Kahlbaum KL. Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstörungen [The arrangement of psychiatric disorders and the classification of disorders of the mind]. Danzig: AW Kafemann, 1863.
21. Hecker E. Die hebephrenie. Virchow's Archiv Patholog Anat Physiolog klin Med 1871;52:394-429.
22. Altschule M. The development of traditional psychopathology: a sourcebook. New York: John Wiley & Sons, 1976.
23. Sedler MJ. The legacy of Ewald Hecker: a new translation of "Die Hebephrenie". Am J Psychiatry 1985;142:1265-1271.
24. Pauleikhoff B. Die katatonie (1868-1968). Fortschr Neurol Psychiatrie 1969;37:461-496.
25. Katzenstein R. Karl Ludwig Kahlbaum und sein Beitrag zur Entwicklung der Psychiatrie. Juris-Verlag: Med Dissert Zurich, 1963:1-42.
26. Diethelm O. Catalepsy and ecstasy. In: Diethelm O, ed. Medical dissertations of medical interest. Basle: Karger, 1971: 71-84.
27. Rosebush P, Mazurek MF. Catatonia: a re-awakening to a forgotten disorder. Movement Disord 1999;14:395-397.
28. Northoff G, Krill W, Wenke J, Travers H, Pflug B. The subjective experience in catatonia: systematic study of 24 catatonic patients. Psychiatr Praxis 1996;23:69-73.
29. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51:357-362.
30. Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989;146:717-725.
31. Harms E. Die entwicklung der kinderpsychiatrie [Development of infantile psychiatry]. Prax Kinderpsychol 1962;11:81-85.
32. Kraepelin E. Hundert Jahre Psychiatrie. Ein Beitrag zur Geschichte menschlicher Gesittung. Zeits Neurol 1918;38:161-275. One Hundred Years of Psychiatry. Baskin W, trans. New York: Philosophical Library, 1962: 116-117.
33. Magrinat G, Danziger JA, Lorenzo IC, Flemenbaum A. A reassessment of catatonia. Compr Psychiatry 1983;24:218-228.
34. Steinberg H. Karl Ludwig Kahlbaum - Leben und Werk bis zur Zeit seines Bekanntwerdens. Fortschr Neurol Psychiatrie 1999;67:367-372.
35. Bräunig P, Krüger S. Karl Ludwig Kahlbaum 1828-1899 (Images in Psychiatry). Am J Psychiatry 1999;156:989.
36. Bräunig P, Krüger S. Karl Ludwig Kahlbaum (1828-1899) - a protagonist in modern psychiatry. Psychiatr Praxis 2000;27:112-118.
37. Wallace AR. My life. New York: Dodd, Mead & Co., 1905.
38. Kiernan JG. Katatonia, a clinical form of insanity. Am J Insanity 1877; 34: 59-91; repr. Am J Psychiatry, 1994; 151:103-111.
39. Spitzka EC. Insanity. Its classification, diagnosis and treatment. New York: Bermingham & Co., 1883; repr. New York: EB Treat, 1887; and New York: Arno Press, 1973.
40. Neisser C. Karl Ludwig Kahlbaum (1828-1899). In: Kirchhoff TH, ed. Deutsche Irrenärzte. Einzelbilder ihres Lebens und Wirkens. Berlin: Springer, 1924, Bd 2: 87-96.
41. Von Schüle H. Zur katatonie-frage: eine klinische studie. Allg Zeits Psychiatrie 1898;54:515-552.
42. Aschaffenburg G. Die Katatoniefrage. Allg Zeits Psychiatrie 1898;54:1004-1026.
43. Kraepelin E. Psychiatrie: ein kurzes Lehrbuch für Studirende und Aertzte, 2nd edn. Leipzig: Ambr. Abel, 1887.
44. Taylor MA, Fink M. Melancholia: The diagnosis, pathophysiology, and treatment of depressive illness. Cambridge UK: Cambridge University Press, 2006.
45. Kraepelin E. Compendium der psychiatrie. Leipzig: Abel, 1883.
46. Bleuler E. Dementia praecox or the group of schizophrenias. 1911. Translated by J. Zinkin. New York: International Universities Press, 1950.
47. Barry JM. The great influenza. New York: Penguin Books, 2004.
48. Von Economo C. Die Encephalitis Lethargica, ihre Nachkrankheiten und ihre Behandlung. Berlin: Urban and Schwarzenberg, 1929. Published in English London: Oxford University Press, 1931.
49. Sacks O. Awakenings. New York: Doubleday & Co, 1974.
50. Personal notes of the meeting in New York City May 1-4, 1996.
51. Taylor MA. Hippocrates cried. The decline of American psychiatry. New York: Oxford University Press, 2013.
52. Johnson J. Catatonia: the tension insanity. Br J Psychiatry 1993;162:733-738.
53. Urstein M. Manisch-depressives und Periodisches Irresein als erscheinungsform der Katatonie. Berlin: Urban & Schwartzberg, 1912.
54. Lange J. Katatonische Erscheinungen im Rahmen manischer Erkrankungen (Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie, Vol 31). Berlin: Julius Springer, 1922.
55. Hoch A. Benign stupors. New York: Macmillan Co., 1921.
56. Bleckwenn WJ. The production of sleep and rest in psychotic cases. Arch Neurol Psychiatry 1930;24:365-372.
57. Bleckwenn WJ. Catatonia cases after IV sodium amytal injection [motion picture]. National Library of Medicine, ID 8501040A.
58. El-Hai J. The lobotomist. New York: John Wiley & Sons, 2005.
59. Kesey K. One flew over the Cuckoo's nest. New York: Signet, 1963.
60. Gazdag G, Bitter I, Ungvari GS, Baran B, Fink M. Laszlo Meduna's pilot studies with camphor induction of seizures. J ECT 2009;25:3-11.
61. Fink M. Is EST a useful therapy of schizophrenia? In: Brady JP, Brodie HKH, eds. Controversy in psychiatry. Philadelphia: WB Saunders, 1978; 183-193.
62. Fink M. EST and other somatic therapies in schizophrenia. In: Bellak L, ed. Disorders of the schizophrenic syndrome. New York: Basic Books, 1979, ch. 10:353-363.
63. Mahendra B. Where have all the catatonics gone? Psychol Med 1981;11:669-671.
64. Morrison JR. Catatonia: retarded and excited types. Arch Gen Psychiatry 1973;28:39-41.
65. Morrison JR. Catatonia: prediction of outcome. Compr Psychiatry 1974;15:317-324.
66. Taylor MA, Abrams R. Catatonia: prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977;34:1223-1225.
67. Bräunig P, Krüger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry 1998;39:35-46.
68. Bell LV. On a form of disease resembling some advanced stages of mania and fever. Am J Insanity 1849;6:97-127.
69. Sakel M. The pharmacological shock treatment of schizophrenia, Wortis J., translator. New York: Nervous and Mental Disease Publishing Co., 1938.
70. Fink M, Shaw R, Gross G, Coleman FS. Comparative study of chlorpromazine and insulin coma in the therapy of psychosis. JAMA 1958;166:1846-850.
71. Fink M. A beautiful mind and insulin coma: social constraints on psychiatric diagnosis and treatment. Harv Rev Psychiatry 2003;11:284-290.
72. Wiseman F. Titicut follies [motion picture], 1967.
73. Flügel F. Parkinson like manifestations produced by medications. Med Klin (Munich) 1955;50:634-635.
74. Rosenheck RA, Leslie DL, Sindelar J et al. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Am J Psychiatry 2006;163:2080-089.
75. Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res 1997;27:83-92.
76. Delay J, Pichot P, Lemperière T, Elisalde B, Peigne F. Un neuroleptique majeur non phenothiazine et non reserpinique, l'haloperidol, dans le traitement des psychoses. Ann Méd Psychol 1960;118:145-152.
77. Delay J, Deniker P. Drug-induced extrapyramidal syndromes. In: Vinken PJ, Bruyn OW, eds. Handbook of clinical neurology, Vol. 6: Disease of the Basal Ganglia. New York: Elsevier, 1968, 248-266.
78. Meltzer HY. Rigidity, hyperpyrexia and coma following fluphenazine enanthate. Psychopharmacologia 1973;29:337-346.
79. Powers P, Douglass TS, Waziri R. Hyperpyrexia in catatonic states. Dis Nerv Syst 1976;37:359-361.
80. Weinberger DR, Kelly MJ. Catatonia and malignant syndrome: a possible complication of neuroleptic administration. J Nerv Ment Dis 1977;165:263-268.
81. Gelenberg AJ. The catatonic syndrome. Lancet 1976;1:1339-1341.
82. Gelenberg AJ. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977;34:947-590.
83. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41:79-83.
84. White D, Robins AH. Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991;158:419-421.
85. White D. Catatonia and the neuroleptic malignant syndrome - a single entity. Br J Psychiatry 1992;161:558-560.
86. Fink M. Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 1996;39:1-4.
87. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia: I: rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-136.
88. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia II: treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137-143.
89. Meduna L. Versuche über die biologische Beeinflussung des Ablaufes der Schizophrenie: Camphor und Cardiozolkrämpfe. Zeits ges Neurol Psychiatr 1935;152:235-262.
90. Fricchione GL, Cassem NH, Hooberman D, Hobson D. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharm 1983;3(6):338-342.
91. Wetzel H, Benkert O. Lorazepam for treatment of catatonic symptoms and severe psychomotor retardation. Am J Psychiatry 1988;145:1175-1176.
92. Harris D, Menza MA. Benzodiazepines and catatonia: a case report. Can J Psychiatry 1989;34:725-727.
93. Benazzi F. Parenteral clonazepam for catatonia. Can J Psychiatry 1991;36:312.
94. McEvoy JP, Lohr JB. Diazepam for catatonia. Am J Psychiatry 1984;141:284-285.
95. Thomas P, Rascle C, Mastain B, Maron M, Vaiva G. Test for catatonia with zolpidem. Lancet 1997;349:702.
96. Rosebush PI, Stewart T, Mazurek MF. The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care? Br J Psychiatry 1991;159:709-712.
97. Keck PE, Caroff SN, McElroy Sl. Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy? J Neuropsychiatry Clin Neurosci 1995;7:135-144.
98. Caroff S, Mann SC, Francis A, Fricchione GL. Catatonia: from psychopathology to neurobiology. Arlington VA: American Psychiatric Publishing, 2004.
99. Morrison JR. Catatonia: diagnosis and management. Hosp Commun Psychiatry 1975;26:91-94.
100. Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci 2001;251(Suppl. 1):8-13.
101. Grinnell F. The scientific attitude, 2nd edn. New York: Guilford Press, 1992.
102. Fink M. Electroshock: restoring the mind. New York: Oxford University Press, 1999. (Re-issued in paperback as Electroshock: healing mental illness, 2002.)
103. Fricchione GL, Kaufman LD, Gruber BL, Fink M. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus erythematosus. Am J Med 1990;88:442-443.
104. Stauder KH. Die tödliche Katatonie. Arch Psychiatrie nervenkr 1934;102:614-634.
105. Calmeil Louis. Traité des maladies inflammatoires du cerveau. Paris: Baillière, 1859, vol 1.
106. Arnold OH. Behandlungsergebnisse bei der akuten tödlichen katatonie. Wien Med Wschr 1953;103:91-94.
107. Taylor MA, Abrams R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry 1973;29:520-522.
108. Bond TC. Recognition of acute delirious mania. Arch Gen Psychiatry 1980;37:553-554.
109. Fink M. Delirious mania. Bipolar Disord 1999;1:54-60.
110. Weintraub D, Lippmann S. Delirious mania in the elderly. Int J Geriatr Psychiatry 2001;16:374-377.
111. Friedman RS, Mufson MJ, Eisenberg TD, Patel MR. Medically and psychiatrically ill: the challenge of delirious mania. Harv Rev Psychiatry 2003;11:91-98.
112. Karmacharya R, England ML, Ongür D. Delirious mania: clinical features and treatment response. J Affect Dis 2008;109:312-316.
113. Detweiler MB, Mehra A, Rowell T, Kim KY, Bader G. Delirious mania and malignant catatonia: a report of 3 cases and review. Psychiatr Q 2009;80:23-40.
114. Lee BS, Huang S-S, Hsu W-Y, Chiu N-Y. Clinical features of delirious mania: a series of five cases and a brief literature review. BMC Psychiatry 2012;12:65 Epub 2012 Jun 21.
115. Arnold OH, Stepan H. Untersuchungen zur Frage der akuten tödliche Katatonie. Wien Zeits Nervenheilk Grenzgeb 1952;4:235-287.
116. Mann SC, Caroff SN, Bleier HR, Welz WKR, Kling MA, Hayashida M. Lethal catatonia. Am J Psychiatry 1986;143:1374-1381.
117. Mann SC, Caroff SN, Keck PE, Lazarus A. Neuroleptic malignant syndrome and related conditions, 2nd edn. Arlington VA: American Psychiatric Publishing Co, 2003.
118. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994;6:1-13.
119. Kapstan A, Miodownick C, Lerner V. Oneiroid syndrome: a concept for use for western psychiatry. Isr J Psychiatry Relat Sci 2000;37:278-85.
120. Meduna L. Oneirophrenia. Urbana, IL: University Illinois Press, 1950.
121. Kramp P, Bolwig TG. Electroconvulsive therapy in acute delirious states. Compr Psychiatry 1981;22:368-371.
122. Malur C, Fink M, Francis A. Can delirium relieve psychosis? Compr Psychiatry 2000;41:450-453.
123. Fink M. The interaction of delirium and seizures. Sem Clin Neuropsychiatry 2000;5:93-97.
124. Shorter E. What historians and clinicians can learn from the history of medicine: the example of fatal catatonia. Med e Storia 2011;21/22:5-17.
125. Ross DL. Factors associated with excited delirium deaths in police custody. Mod Pathol 1998;11:1127-1137.
126. Fink M. Toxic serotonin syndrome or neuroleptic malignant syndrome? Case report. Pharmacopsychiatry 1996;29:159-161.
127. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-713.
128. Insel TR, Roy BF, Cohen RM, Murphy DL. Possible development of the serotonin syndrome in man. Am J Psychiatry 1982;139:954-955.
129. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998;248:96-103.
130. Gillman PK. Serotonin syndrome: history and risk. Fundam Clin Pharmacol 1998;12:482-491.
131. Carbone JR. The neuroleptic malignant and serotonin syndromes. Emerg Med Clin North Am 2000;18:317-325.
132. Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore) 2000;79:201-209.
133. Odagaki Y. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? Curr Drug Saf 2009;4:84-93.
134. Nisijima K, Nibuya M, Kato S. Toxic serotonin syndrome successfully treated with electroconvulsive therapy. J Clin Psychopharmacol 2002;22:338-339.
135. Okamoto N, Sakamoto K, Nagafusa Y, Ichikawa M, Nakai T, Higuchi T. Electroconvulsive therapy as a potentially effective treatment for serotonin syndrome: two case reports. J Clin Psychopharmacol 2010;30:350-352.
136. Carroll BT, Lee JW, Graham KT, Thalassinos A, Thomas C, Kirkhart R. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll scale. Ann Clin Psychiatry 2008;20:47-48.
137. Lee JWY. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome. Ann Clin Psych 2007;19:9-16.
138. Shorter E. Making childhood catatonia visible, separate from competing diagnoses. Acta Psychiatr Scand 2012;125:3-10.
139. Dhossche DM, Wing L, Ohta M, Neumärker K-J, editors Catatonia in autism spectrum disorders. Int Rev Neurobiology 2007;72:1-314.
140. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943;2:217-250.
141. Asperberger H. Die 'Autistischen Psychopathen' in Kindersalter. Arch Psychiatrie Nervenheilkr 1944;117:76-136.
142. Centers for Disease Control and Prevention. Data and Statistics, Autism Spectrum Disorders. www.cdc.gov/NCBDDD/autism/data.html.
143. Wing L, Shah A. Catatonia in autism spectrum disorders. Br J Psychiatry 2000;176:357-362.
144. Billstedt E, Gillberg IC, Gillberg C. Autism after adolescence: population based 13 to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord 2005;35:351-360.
145. Dhossche DM, Reti IM, Wachtel LE. Catatonia and autism: a historical review, with implications for electroconvulsive therapy. J ECT 2009;25:19-22.
146. Fink M. Electroconvulsive therapy: a guide for professionals & their patients. New York: Oxford University Press, 2009.
147. Jap SN, Ghaziuddin N. Catatonia among adolescents with down syndrome: a review and 2 cases. J ECT 2011;27:334-337.
148. Bailine SH, Petraviciute S. Catatonia in autistic twins: role of electroconvulsive therapy. J ECT 2007;23:21-22.
149. Wachtel LE, Crawford TO, Dhossche DM, Reti IM. Electroconvulsive therapy for pediatric malignant catatonia with cerebellar dysgenesis. Pediatr Neurol 2010;43:427-430.
150. Dhossche DM, Reti IM, Shettar SM, Wachtel LE. Tics as signs of catatonia: electroconvulsive therapy response in 2 men. J ECT 2010;26:266-269.
151. Wachtel LE, Contrucci-Kuhn SA, Griffin M, Thompson A, Dhossche DM, Reti IM. ECT for self-injury in an autistic boy. Eur Child Adolesc Psychiatry 2009;18:458-463.
152. Wachtel LE, Kahng SW, Dhossche DM, Cascella N, Reti IM. ECT for catatonia in an autistic girl. Am J Psychiatry 2008;165:329-333.
153. Wachtel LE, Griffin M, Reti IM. Electroconvulsive therapy in a man with autism experiencing severe depression, catatonia, and self-injury. J ECT 2010;26:70-73.
154. Ghazziuddin N, Gih D, Barbosa V, Maixner DF, Ghaziuddin M. Onset of catatonia at puberty: electroconvulsive therapy response in two autistic adolescents. J ECT 2010;26:274-277.
155. Bozkurt H, Mukaddes NM. Catatonia in a child with autistic disorder. Turk J Pediatr 2010;52:435-438.
156. de Winter CF, van Dijk F, Verhoeven WM, Dhossche DM, Stolker JJ. Autism and catatonia: successful treatment using lorazepam. A case study. Tijdschr Psychiatr 2007;49:257-261.
157. Thuppal M, Fink M. Electroconvulsive therapy and mental retardation. JECT 1999;15:140-9.
158. Collins J, Halder N, Chaudhry N. Use of ECT in patients with an intellectual disability: review. Psychiatrist 2012;36:55-60.
159. Robertson MM. The Gilles de la Tourette syndrome: current status. Br J Psychiatry 1989;154:147-169.
160. Cavanna AE, Robertson MM, Critchley HD. Catatonic signs in Gilles de la Tourette syndrome. Cogn Behav Neurol 2008;21:34-37.
161. Realmuto GM, Main B. Coincidence of Tourette's disorder and infantile autism. J Autism Dev Disord 1982;12:367-372.
162. McNaught KS, Mink JW. Advances in understanding and treatment of Tourette syndrome. Nat Rev Neurol 2011;7:667-676.
163. Robertson MM, Stern JS. Gilles de la Tourette syndrome: symptomatic treatment based on evidence. Eur Child Adolesc Psychiatry 2000;9(Suppl. 1):160-175.
164. Pringsheim T, Marras C. Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev 2009;2:CD006996.
165. Van den Eeynde F, Naudts KH, De Saedeleer S, van Heeringen C, Audenaert K. Olanzapine in Gilles de la Tourette syndrome: beyond tics. Acta Neurol Belg 2005;105:206-211.
166. Martinez-Fernández R, Zrinzo L, Aviles-Olmos I et al. Deep brain stimulation for Gilles de la Tourette syndrome: a case series targeting subregions of the globus pallidus internus. Mov Disord 2011;26:1922-930.
167. Trivedi H, Mendelowitz A, Fink M. A Gilles de la Tourette form of catatonia: response to ECT. J ECT 2003;19:115-117.
168. Guttmacher LB, Cretella H. Electroconvulsive therapy in one child and three adolescents. J Clin Psychiatry 1988;49:20-23.
169. Rapoport M, Feder V, Sandor P. Response of major depression and Tourette's syndrome to ECT: a case report. Psychosom Med 1998;60:528-529.
170. Strassnig M, Riedel M, Müller N. Electroconvulsive therapy in a patient with Tourette's syndrome and co-morbid obsessive compulsive disorder. World J Biol Psychiatry 2004;5:164-166.
171. Karadenizili D, Dilbaz N, Bayam G. Gilles de la Tourette syndrome: response to electroconvulsive therapy. J ECT 2005;21:246-248.
172. Dehning S, Feddersen B, Mehrkens J-H, Müller N. Long-term results of electroconvulsive therapy in severe Gilles de la Tourett syndrome. J ECT 2011;27:145-147.
173. Kaim B. A case of Gilles de la Tourette syndrome treated with clonazepam. Brain Res Bull 1983;11:213-214.
174. Gonce M, Barbeau A. Seven cases of Gilles de la Tourette's syndrome: partial relief with clonazepam: a pilot study. Can J Neurol Sci 1977;4:279-283.
175. Kuniyoshi M, Inanaga K, Anikama K, Maeda Y, Nakamura J, Uchimura N. A case of tardive Tourette-like syndrome. Jpn J Neurol Psychiatry 1992;46:67-70.
176. Lask B, Britten C, Kroll L, Magagna J, Tranter M. Children with pervasive refusal. Arch Dis Child 1991;66:866-9.
177. Jaspers T, Hanssen GMJ, vander Valk JA, Hanekom JH, van Well GTJ, Schieveld JNM. Pervasive refusal syndrome as part of refusal-withdrawal-regression spectrum: critical review of the literature illustrated by a case report. Eur Child Adolesc Psychiatry 2009;18:645-651.
178. Guirguis S, Reid C, RaoS, Grahame V, Kaplan C. Follow-up study of four cases of pervasive refusal syndrome. Eur Child Adolesc Psychiatry 2011;20:271-274.
179. Christensen AM, Thelle T. Pervasive refusal syndrome in a 12-year-old boy. Ugeskr Laeger 2011;173:1214-1215.
180. Wright B, Beverley D. Pervasive refusal syndrome. Clin Child Psychol Psychiatry 2012;17(2):221-8. Epub 2011 July 6.
181. McNicholas F, Prior C, Bates G. A case of pervasive refusal syndrome: a diagnostic conundrum. Clin Child Psychol Psychiatry 2012; Epub July 18, 2012.
182. Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol 2010;4:307-315.
183. Dhossche D, Ross CA, Stoppelbein L. The role of deprivation, abuse, and trauma in pediatric catatonia without a clear medical cause. Acta Psychiatr Scand 2012;125:33-38.
184. Bodegård G. Pervasive loss of function in asylum-seeking children in Sweden. Acta Pediatr 2005;94:1206-1207.
185. Von Folsach LL, Montgomery E. Pervasive refusal syndrome among asylum-seeking children. Clin Child Psychol Psychiatry 2006;11:457-473.
186. Dalmau J. Clinical experience and laboratory investigation in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
187. Sabin TD, Jednacz JA, Staats PN. Case records of the Massachusetts General Hospital; Case 26. 2008. a 26-year-old woman with headache and behavioral changes. New Eng J Med 2008;359:842-853.
188. Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 2011;168:245-251.
189. Dhossche D, Fink M, Shorter E, Wachtel LE. Anti-NMDA receptor encephalitis versus pediatric catatonia. Am J Psychiatry 2011;168:749-750.
190. Dalmau J, Gleichman AJ, Hughes EG et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.
191. Kung DH, Qiu C, Kass JS. Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor. Psychosomatics 2011;52:82-85.
192. Lennox BR, Coles AJ, Vincent A. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry 2012;200:92-94.
193. Pollak TA, Lennox BR, Vincent A, Nicholson TR. Antibody-mediated encephalitis and psychosis [letter]. Br J Psychiatry 2012;200:344.
194. Kaestner F, Mostert C, Behnken A et al. Therapeutic strategies for catatonia in paraneoplastic encephalitis. World J Biol Psychiatry 2008;9:236-240.
195. Creten C, van der Zwaan S, Blankespoor J et al. Late onset autism and anti-NMDA-receptor encephalitis. Lancet 2011;378:98.
196. Braackman HMH, Moers-Hornikx VMP, Ars BMG, Hupperts RMM, Nicolai J. Electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology 2010;75:e45-e46.
197. Lee A, Glick DB, Dinwiddie DH. Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis. J ECT 2006;22:267-270.
198. Romanowicz M, Sola CL. Electroconvulsive therapy-responsive catatonia in a medically complicated patient. J ECT 2010;26:234-237.
199. Fontanelle LF, Lauterbach EC, Telles LL, Versiani M, Porto FH, Mendlowicz MV. Catatonia in obsessive-compulsive disorder: Etiopatogenesis, differential diagnosis and clinical management. Cog Behav Neurol 2007;20:21-24.
200. Hermesh H, Hoffnung RA, Aizenberg D, Molcho A, Munitz H. Catatonic signs in severe obsessive compulsive disorder. J Clin Psychiatry 1989;50:303-305.
201. Leonard HL, Topol D, Bukstein O, Hindmarsh D, Allen AJ, Swedo SE. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder. J Am Child Adolesc Psychiatry 1994;33:792-794.
202. Crockett BA, Churchill E, Davidson JR. A double-blind combination study of clonazepam with sertraline on obsessive-compulsive disorder. Ann Clin Psychiatry 2004;16:127-132.
203. Hollander E, Kaplan A, Stahl SM. A double-blind placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J Biol Psychiatry 2003;4:30-34.
204. Maletzky B, McFarland B, Burt A. Refractory obsessive compulsive disorder and ECT. Convulsive Ther 1994;10:34-42.
205. Soyka M, Niederecker M, Meyendorf R. Erfolgreiche Behandlung eines therapieresistenten Zwangssyndroms durch Elektrokrampftherapie. Nervenarzt 1991;62/64:448-450.
206. Khanna S, Gangadhar BN, Sinha V, Rajendra PN, Channabasavanna SM. Electroconvulsive therapy in obsessive-compulsive disorder. Convulsive Ther 1988;44:314-320.
207. Mellman LA, Gorman JM. Successful treatment of obsessive-compulsive disorder with ECT. Am J Psychiatry 1984;141:596-597.
208. Raveendrathan D, Srinivasaraju R, Ratheesh A, Math SB, Reddt YCJ. Treatment-refractory OCD responding to maintenance electroconvulsive threapy. J Neuropsychiat Clin Neurosci 2012;24:e16-e17.
209. Klee A. Akinetic mutism: review of the literature and report of a case. J Nerv Ment Dis 1961;133:536-553.
210. Formisano R, D'Ippolito M, Risetti M et al. Vegetative state, minimally conscious state, akinetic mutism and Parkinsonism as a continuum of recovery from disorders of consciousness. Funct Neurol 2011;26:15-24.
211. Cairns H, Oldfield RC, Pennybacker JB, Whittridge D. Akinetic mutism with an epidermoid cyst of the third ventricle. Brain 1941;64:273-290.
212. Cairns H. Disturbances of consciousness with lesions of the brain-stem and diencephalon. Brain 1952;75:109-146.
213. Cravioto H, Silberman J, Feigin I. A clinical and pathologic study of akinetic mutism. Neurology 1960;8:10-21.
214. Sours JA. Akinetic mutism simulating catatonic schizophrenia. Am J Psychiatry 1962;119:451-455.
215. Dalle OreG, Gerstenbrand F, Lücking CH, Peters G, Peters UH. The Apallic syndrome. Berlin: Springer Verlag, 1977.
216. Bauer G, Gerstenbrand F, Rumpl E. Varieties of the locked-in syndrome. J Neurol 1979;221:77-91.
217. Blum P, Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord 1991;6:12-20.
218. Barker RA, Revesz T, Thom M, Marsden CD, Brown P. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndromes, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998;65:633-640.
219. Fisher CM. 'Catatonia' due to disulfiram toxicity. Arch Neurol 1989;46:798-804.
220. Gheuens S, Michotte A, Flamez A, De Keyser J. Delayed akinetic catatonic mutism following methadone overdose. Neurotoxicology 2010;3:762-764.
221. Wijdicks EF, Cranford RE. Clinical diagnosis of prolonged states of impaired consciousness in adults. Mayo Clin Proc 2005;80:1037-1046.
222. Williams D, Parsons-Smith G. Thalamic activity in stupor. Brain 1951;74:377-398.
223. Brefel-Courbon C, Payoux P, Ory F et al. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol 2007;62:102-105.
224. Lukowicz M, Matuszak K, Talar A. A misdisagnosed patient: 16 years of locked-in syndrome, the influence of rehabilitation. Med Sci Monit 2010;18:CS18-CS23.
225. Laureys S, Pellas F, Van EeckhoutP et al. The locked-in syndrome: what is it like to be conscious but paralyzed and voiceless? Prog Brain Res 2005;150:495-511.
226. Thomson T, Hooker JD. Flora Indica: A systematic account of the plants of British India. London: W. Pamplin, 1855, 10-11.
227. World Health Organization. The International classification of diseases [ICD]. Geneva: WHO, 1949; revised 1965, 1975, and 1982.
228. American Psychiatric Association. Diagnostic and statistical manual: mental disorders [DSM-I]. Washington, DC: APA, 1952.
229. American Psychiatric Association. DSM II: Diagnostic and statistical manual of mental disorders, 2nd edn. Washington, DC: APA, 1968.
230. American Psychiatric Association. DSM-III: Diagnostic and statistical manual of mental disorders, 3rd edn. Washington, DC: APA, 1980.
231. Ries RK. DSM-III implications of the diagnosis of catatonia and bipolar disorder. Am J Psychiatry 1985;142:1471-1474.
232. Strand M. Where do classifications come from? The DSM-III, the transformation of American psychiatry, and the problem of origins in the sociology of knowledge. Theor Soc 2011;40:273-313.
233. Francis A, Fink M, Appiani F et al. Catatonia in Diagnostic and statistical manual of mental disorders, Fifth edition [letter]. J ECT 2010;26:246-248.
234. Dhossche D, Cohen D, Ghaziuddin N, Wilson C, Wachtel LE. The study of pediatric catatonia supports a home of its own for catatonia. Med Hypoth 2010;75:558-560.
235. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizoph Bull 2010;36:314-320.
236. Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull 2010;36:239-242.
237. Ungvari G, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena disorders. Schizophr Bull 2010;36:231-238.
238. Heckers S, Tandon R, Bustillo J. Catatonia in the DSM - Shall we move or not? Schizophr Bull 2010;36:205-207.
239. Schizophrenia spectrum and other psychotic disorders [Internet]. American psychiatric association. DSM-5 Development. Arlington, VA: APA, 2012; cited 2012 July 28]. Available from: http://www.dsm5.org/ProposedRevision/Pages/SchizophreniaSpectrumandOtherPsychoticDisorders.aspx.
240. Taylor MA, Shorter E, Vaidya NA, Fink M. The failure of the schizophrenia concept and the argument for its replacement by hebephrenia: applying the medical model for disease recognition. Acta Psychiatr Scand 2010;122:173-183.
241. Holmes OW. Professor at the breakfast table. Boston: Houghton Mifflin & Co., 1891.
242. Perkins RJ. Catatonia:The ultimate response to fear? Aust NZ J Psychiatry 1982;16:282-287.
243. Abram HS. Psychotic reactions after cardiac surgery: a critical review. Sem Psychiatry 1971;3:70-78.
244. Wetzel H, Heuser I, Benkert O. Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788. J Nerv Ment Dis 1987;175:240-242.
245. Myslobodsky M, Kohman O, Mintz M. Convulsant-specific architecture of the postictal behavior syndrome in the rat. Epilepsia 1981;22:559-568.
246. Gallmetzer P, Leutmezer F, Serles W, Assem-Hilger E, Spatt J, Baumgartner C. Postictal paresis in focal epilepsies - incidence, duration, and causes: a video-EEG monitoring study. Neurology 2004;62:2160-2164.
247. Gallup GG. Tonic immobility: the role of fear and predation. Psychol Rec 1977;1:41-61.
248. Beach SR, Stern TA. "Playing possum": differential diagnosis, work-up, and treatment of profound interpersonal withdrawal. Psychosomatics 2011;52:560-562.
249. LeDoux J. Fear and the brain: where have we been, and where are we going? Biol Psychiatry 1998;44:1229-1238.
250. McGillis K. Memoir of a brief time in hell. People. 1988 14;154.
251. Marx BP, Forsyth JP, Lexington JM. Tonic immobility as an evolved predator defense. Implications for sexual assault survivors. Clin Psychol Sci Prac 2008;15:74-90.
252. Galliano G, Noble LM, Travis LA, Puechl C. Victim reactions during rape/sexual assault. J Interpers Violence 1993;8:109-114.
253. Fiszman A, Mendlowicz MV, Marques-Portella C et al. Peritraumatic tonic immobility predicts a poor response to pharmacological treatment in victims of urban violence with PTSD. J Affective Dis 2008;107:193-197.
254. Goetz M, Kitzlerova E, Hrdlicka M, Dhossche D. Combined use of ECT and amantadine in adolescent catatonia precipitated by cyber-bullying. Jrl Child & Adolesc Psychopharmacology (in press) 2013.
255. Volchan E, Souza GG, Franklin CM et al. Is there tonic immobility in humans? Biological evidence from victims of traumatic stress. Biol Psychol 2011;88:13-19.
256. Cortese BM, Uhde TW. Immobilization panic. Am J Psychiatry 2006;163:1453-1454.
257. Fink M. Electroshock revisited. Am Sci 2000;88:162-167.
258. Bell MS. Lavoisier in the year one. New York: WW Norton, 2005.
259. Fink M, Taylor MA. The medical evidence-based model to identify psychiatric syndromes: return to a classical paradigm. Acta Psychiatr Scand 2008;87:81-84.
260. Fink M, Rush AJ, Knapp R DSM melancholic features are unreliable predictors of ECT response: a CORE publication. J ECT 2007;23:139-146.
261. Parker G, Hadzi-Pavlovic D. Melancholia: a disorder of movement and mood. Cambridge UK: Cambridge University Press, 1996.
262. Bolwig TM, Shorter E, guest editors. Melancholia: Beyond DSM, beyond neurotransmitters. Acta Psychiatr Scand 2007;155(Suppl. 433):1-183.
263. Taylor MA, Fink M. Restoring melancholia in the classification of mood disorders. J Affect Disord 2008;105:1-14.
264. Shorter E, Fink M. Endocrine psychiatry: solving the riddle of melancholia. New York: Oxford University Press, 2010.
265. Parker G, Fink M, Shorter E et al. Whither melancholia? The case for its classification as a distinct mood disorder [editorial]. Am J Psychiatry 2010;167:745-747.
266. Ottosson J-O, Fink M. Ethics of electroconvulsive therapy. New York: Brunner-Routledge, 2004.